SHINE Medical Technologies raises $94.6 million

Tracy Radel, SHINE’s vice president of engineering, conducts a tour of the company’s medical isotope production facility in Janesville, with Greg Piefer, chief executive officer, at right.
Tracy Radel, SHINE’s vice president of engineering, conducts a tour of the company’s medical isotope production facility in Janesville, with Greg Piefer, chief executive officer, at right.

The parent company of medical isotope manufacturer SHINE Medical Technologies raised $94.6 million, according to a recent filing with the U.S. Securities and Exchange Commission. Illuminated Holdings Inc., the parent company of Shine, also raised $131.7 million in an April round of funding. SHINE did not immediately respond to a request for comment. However, in

Already a Subscriber? Log in

To Continue Reading This Article

Become a BizTimes Insider today and get immediate access to our subscriber-only content and much more.

Learn More and Become a Subscriber

Sign up for the BizTimes email newsletter

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display